Small-Molecule PD-L1 Modulators as Alternatives to Checkpoint Antibodies: Implications for Infection-Associated Immune Toxicities. JISEES [Internet]. 2025 Oct. 21 [cited 2026 Mar. 10];:088. Available from: https://journals.ysu.am/jisees/article/view/SI_1_2025_p088